IL122737A - Salts of amidine derivatives and cyclooxygenase inhibitors, their preparation and pharmaceutical compositions containing them - Google Patents

Salts of amidine derivatives and cyclooxygenase inhibitors, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL122737A
IL122737A IL12273796A IL12273796A IL122737A IL 122737 A IL122737 A IL 122737A IL 12273796 A IL12273796 A IL 12273796A IL 12273796 A IL12273796 A IL 12273796A IL 122737 A IL122737 A IL 122737A
Authority
IL
Israel
Prior art keywords
salts
pharmaceutical compositions
compositions containing
pct
preparation
Prior art date
Application number
IL12273796A
Other versions
IL122737A0 (en
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of IL122737A0 publication Critical patent/IL122737A0/en
Publication of IL122737A publication Critical patent/IL122737A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PCT No. PCT/FR96/01095 Sec. 371 Date Jan. 6, 1998 Sec. 102(e) Date Jan. 6, 1998 PCT Filed Jul. 15, 1996 PCT Pub. No. WO97/03678 PCT Pub. Date Feb. 6, 1997Cyclo-oxygenase inhibitor and amidine derivative salts, preparation methods therefor, pharmaceutical compositions containing said salts and the use thereof particularly as NO synthase and cyclo-oxygenase inhibitors, are disclosed.
IL12273796A 1995-07-15 1996-07-15 Salts of amidine derivatives and cyclooxygenase inhibitors, their preparation and pharmaceutical compositions containing them IL122737A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9514518.1A GB9514518D0 (en) 1995-07-15 1995-07-15 Guanidine salt inhibitors of NO synthase and cyclooxygenase
PCT/FR1996/001095 WO1997003678A1 (en) 1995-07-15 1996-07-15 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts

Publications (2)

Publication Number Publication Date
IL122737A0 IL122737A0 (en) 1998-08-16
IL122737A true IL122737A (en) 2003-01-12

Family

ID=10777740

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12273796A IL122737A (en) 1995-07-15 1996-07-15 Salts of amidine derivatives and cyclooxygenase inhibitors, their preparation and pharmaceutical compositions containing them

Country Status (24)

Country Link
US (1) US6063807A (en)
EP (1) EP0839041B1 (en)
JP (1) JPH11509540A (en)
CN (1) CN1187056C (en)
AT (1) ATE264107T1 (en)
AU (1) AU704373B2 (en)
CA (1) CA2227034A1 (en)
CZ (1) CZ293676B6 (en)
DE (1) DE69632193T2 (en)
DK (1) DK0839041T3 (en)
ES (1) ES2219690T3 (en)
GB (1) GB9514518D0 (en)
HU (1) HUP9901331A3 (en)
IL (1) IL122737A (en)
MX (1) MX9800408A (en)
NO (1) NO980178L (en)
NZ (1) NZ313654A (en)
PL (1) PL185375B1 (en)
PT (1) PT839041E (en)
RU (1) RU2167856C2 (en)
TW (1) TW474908B (en)
UA (1) UA53624C2 (en)
WO (1) WO1997003678A1 (en)
ZA (1) ZA965969B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925351A (en) 1995-07-21 1999-07-20 Biogen, Inc. Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
US7255854B1 (en) 1996-10-25 2007-08-14 Biogen, Inc. Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases
CO5261556A1 (en) * 1999-12-08 2003-03-31 Pharmacia Corp CYCLLOXYGENASE-2 INHIBITING COMPOSITIONS THAT HAVE FAST THERAPEUTIC EFFECT ACCESS
US20020147216A1 (en) * 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors
PE20020146A1 (en) * 2000-07-13 2002-03-31 Upjohn Co OPHTHALMIC FORMULATION INCLUDING A CYCLOOXYGENASE-2 (COX-2) INHIBITOR
RU2303452C2 (en) 2000-07-20 2007-07-27 Леурас Ас Using cox-2 inhibitors for prophylaxis of immunodeficiency
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
US7695736B2 (en) 2001-04-03 2010-04-13 Pfizer Inc. Reconstitutable parenteral composition
UA80682C2 (en) * 2001-08-06 2007-10-25 Pharmacia Corp Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
AR038957A1 (en) 2001-08-15 2005-02-02 Pharmacia Corp COMBINATION THERAPY FOR CANCER TREATMENT
MXPA04009352A (en) * 2002-04-18 2005-01-25 Pharmacia Corp COMBINATION THERAPY FOR THE TREATMENT OF PARKINSONaCOES DISEASE WITH CYCLOOXYGENASE-2 (COX 2) INHIBITOR(S).
MXPA04010186A (en) * 2002-04-18 2005-02-03 Pharmacia Corp MONOTHERAPY FOR THE TREATMENT OF PARKINSONaCOES DISEASE WITH CYCLOOXYGENASE-2 (COX 2) INHIBITOR(S).
US8067375B2 (en) 2006-10-20 2011-11-29 Biogen Idec Ma Inc. Treatment of demyelinating disorders with soluble lymphotoxin-β-receptor
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
US20090155430A1 (en) * 2007-12-14 2009-06-18 E.I. Du Pont De Nemours And Company Films comprising liquid smoke and flavorants
RU2478618C2 (en) * 2010-03-15 2013-04-10 Закрытое Акционерное Общество "Инфарма" New biologically active compound n-[3-(4-nitrophenylamino)-indol-2-ylmethylene]aminoguanidine hydrochloride with antiinflammatory activity
RU2480452C1 (en) * 2012-01-11 2013-04-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная химико-фармацевтическая академия" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СПХФА Минздрава России) Method of producing n-4-nitrophenylbenzamidine
RU2684117C1 (en) * 2018-10-29 2019-04-04 Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный химико-фармацевтический университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России) Method for producing n-(naphthalene-2-yl)benzamidine
CN109678715B (en) * 2018-11-28 2019-11-12 中国药科大学 Salt, the preparation method and the usage that 2- (1- acyl-oxygen n-pentyl) benzoic acid and basic amino acid or aminoguanidine are formed
RU2694263C1 (en) * 2019-02-14 2019-07-11 Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный химико-фармацевтический университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России) Analgesic and anti-inflammatory agent with antimicrobial activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56147761A (en) * 1980-04-15 1981-11-16 Banyu Pharmaceut Co Ltd Salt compound consisting of acetylsalicylic acid and diguanidine, its preparation and agent containing the same as active constitutent
US4324801A (en) * 1981-04-21 1982-04-13 Banyu Pharmaceutical Co. Ltd. Phenylguanidine acetylsalicylate compounds, process for production thereof, and pharmaceutical composition thereof
JPS61143320A (en) * 1985-11-08 1986-07-01 Banyu Pharmaceut Co Ltd Improver for microcirculatory system
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase

Also Published As

Publication number Publication date
US6063807A (en) 2000-05-16
MX9800408A (en) 1998-04-30
DK0839041T3 (en) 2004-08-09
WO1997003678A1 (en) 1997-02-06
CN1187056C (en) 2005-02-02
NZ313654A (en) 1999-10-28
HUP9901331A3 (en) 1999-11-29
JPH11509540A (en) 1999-08-24
PT839041E (en) 2004-09-30
CN1190890A (en) 1998-08-19
TW474908B (en) 2002-02-01
ATE264107T1 (en) 2004-04-15
AU6617596A (en) 1997-02-18
CZ7398A3 (en) 1998-06-17
CA2227034A1 (en) 1997-02-06
HUP9901331A2 (en) 1999-08-30
RU2167856C2 (en) 2001-05-27
UA53624C2 (en) 2003-02-17
PL324490A1 (en) 1998-05-25
ES2219690T3 (en) 2004-12-01
EP0839041B1 (en) 2004-04-14
GB9514518D0 (en) 1995-09-13
IL122737A0 (en) 1998-08-16
NO980178D0 (en) 1998-01-14
AU704373B2 (en) 1999-04-22
ZA965969B (en) 1997-10-31
DE69632193T2 (en) 2005-05-04
DE69632193D1 (en) 2004-05-19
EP0839041A1 (en) 1998-05-06
NO980178L (en) 1998-01-14
PL185375B1 (en) 2003-04-30
CZ293676B6 (en) 2004-06-16

Similar Documents

Publication Publication Date Title
IL122737A (en) Salts of amidine derivatives and cyclooxygenase inhibitors, their preparation and pharmaceutical compositions containing them
ES2083595T3 (en) DERIVATIVES OF INDOL INHIBITING THE BIOSYNTHESIS OF LEUCOTRENE.
MX9707431A (en) Protein kinase c inhibitors.
TR199800759T2 (en) Protein Kinase C Inhibitor.
CY2509B1 (en) New thiazole derivatives with phosphodiesterase-inhibitting effect
AU4308397A (en) Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors
AU2746895A (en) Tetra-substituted phenyl derivatives useful as pde iv inhibitors
HUP0102101A3 (en) Protein tyrosine kinase inhibitor benzothiazole derivatives and pharmaceutical compositions containing them
MX9702307A (en) PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE.
FI956074A0 (en) 1-substituted isatin and oxidol derivatives as acetylcholinesterase inhibitors
AU6142394A (en) New heterocyclic compounds, their preparation and their use
MY124487A (en) Dolastatin derivatives, their preparation and use
GB9514821D0 (en) Galanthamine derivatives
MXPA04004372A (en) Heterocyclic derivatives of glycinamide and their medical use.
GEP20084346B (en) Protein kinase c inhibitors
AU4501199A (en) 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors
AU4415797A (en) New pde iv inhibitors: "bis-compounds"
AU9270598A (en) Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates
AU4944899A (en) New pharmaceutically active compounds
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use
AP9901637A0 (en) Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid.
PL337875A1 (en) Derivatives of 6-azauracil as il-5 inhibitors
TR199701011A2 (en) 1-carb-(detia)-cephalosporin t�revleri.
TW349092B (en) Substituted indole derivatives
MY133139A (en) N-substituted azabicycloheptane derivatives, their preparation and use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees